Clinical application of sciatic nerve block in postoperative analgesia of patients with calcaneal fracture

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042340

Enrollment

Unknown

Registered

2021-01-19

Start date

2021-01-17

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

experimental group:spinal anesthesia+PCIA+sciatic nerve block

control group:Spinal anesthesia+PCIA

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The patients with calcaneal fracture under spinal anesthesia were male and female, ASA grade I-II, aged 18-65 years. We have signed the informed consent and agreed to participate in this clinical study.

Exclusion criteria

Exclusion criteria: Patients with history of cardiovascular disease and infection; patients with history of spontaneous use of ropivacaine for 5 days; patients with history of cardiovascular disease and infection; patients with history of spontaneous use of ropivacaine for 5 days.

Design outcomes

Primary

Measure	Time frame
VAS score;	—

Countries

China

Contacts

Public ContactWang Qiujun

The Third Hospital of Hebei Medical University

13933178001@163.com+86 18533112929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026